Cookie bar

We use cookies and other tracking technologies to improve your experience and analyse our website traffic.

Please consult our Privacy Policy for more information.

By clicking on “Accept”, you consent to your data being collected

You can change your cookie settings and disable cookies, except for essential functional ones, at any time.


Functional
Preference
Statistical
Marketing
FEMTOPRINT SA

INNo-CHIP: Cross-Border Synergy Accelerating the Future of Biomedical Innovation

FEMTOPRINT is proud to play a key role in INNo-CHIP, a visionary cross-border initiative designed to elevate the biomedical sector through strategic collaboration between the Alto Adige (South Tyrol) region and the Canton of Ticino.

By uniting research, innovation, and cutting-edge technology, INNo-CHIP aims to accelerate preclinical research, optimize R&D (Research & Development) costs, and significantly enhance translational outcomes. At the core of this transformation lies a disruptive platform: organ-on-chip (OoC) technology.

 

A New Standard in Preclinical Modeling

Traditional in vitro and in vivo models, while useful, often fall short in replicating the complex physiological responses of the human body. OoC platforms—miniaturized microfluidic systems that mimic the structure and function of human organs—are rapidly becoming the gold standard in preclinical research.

These bioengineered systems offer unparalleled physiological relevance, making them indispensable tools for drug discovery, toxicology, and personalized medicine. By enabling controlled, dynamic environments, OoC technology supports more accurate modeling of human tissue interfaces, reducing animal testing and enhancing predictive validity.

Key Advantages of OoC Platforms:

  • Simulation of human organ-level responses under dynamic flow conditions
  • Integration with microfluidics, MEMS (Micro-Electro-Mechanical Systems), and high-content screening (HCS)

The project’s mission is to create a sustainable, high-impact interregional cluster specialized in biomedical research and advanced microtechnologies, enabling faster access to next-generation therapeutic testing platforms.

 

FEMTOPRINT’s Role: Precision Microfabrication in Biocompatible Glass

Within this collaborative framework, FEMTOPRINT® contributes its world-class expertise in ultrafast laser microfabrication to develop next-generation OoC platforms.

Discover more about our Technology.

 

INNo-CHIP stands at the intersection of innovation, precision, and purpose. It represents a major step forward in the convergence of biomedical engineering, microtechnology, and applied life sciences.

Interested in learning more or exploring collaboration opportunities?
Get in touch with our team to discuss your application or request a technical consultation.

 

Logo Progetto Innochip Logo Cantone Ticino

 

Subscribe to our newsletter

Get informed on the latest developments of our company and leading technology!

Sign up now
Contact Us